There are no upcoming events at this time.

View All
View Full Calendar See All Updates

Get Email Updates

Energy and Commerce Committee

Letter

Filters
Sort Content By:
Subcommittees
Post Types
Categories

Letter to FDA on Lagging Approvals for Complex Generic Drugs

01.17.2020

Excerpt: "We are interested in identifying ways to help reduce the costs of health care for patients, including the costs of prescription drugs. Generic versions of brand-name drugs provide substantial cost savings for patients and third-party payers and account for nine out of ten prescriptions filled in the U.S.," the bipartisan Committee members wrote to FDA.

CLICK HERE to read the letter to FDA.

Letter

Letter to GAO regarding IHS infrastructure

01.17.2020

Excerpt: “It is our commitment and belief that patients seeking care at these facilities should receive high-quality care and that IHS must strive for the highest possible standards of care,” the bipartisan Committee members wrote to GAO. “Unfortunately, IHS hospital administrators have reported that old or inadequate facilities and medical equipment have challenged their ability to provide the highest quality care for patients.”  

CLICK HERE to read the letter to GAO.

Letter

Letter to HHS, CDC, and NIH on Alzheimer’s Disease Research

01.16.2020

Excerpt: "We write to request information about the actions that the U.S. Department of Health and Human Services (HHS) has taken to cultivate innovation in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD or Alzheimer’s) research, as well as barriers that stand in the way of discovering treatments or cures for AD/ADRD, and the ways in which Congress can assist in overcoming such barriers," Walden, Guthrie, and Burgess wrote in their letters. 

CLICK HERE to read the letter to HHS

CLICK HERE to read the letter to CDC

CLICK HERE to...

Letter

Letter to DEA, DHS, and HHS on cocaine and methamphetamine

01.14.2020

Excerpt: “We are concerned that while the nation, rightly so, is devoting much of its attention and resources to the opioid epidemic, another epidemic—this one involving cocaine and methamphetamine—is on the rise,” the bipartisan Committee leaders wrote in their letters. “We remain committed to advance treatment, improve prevention, protect communities, and bolster efforts to fight deadly illicit drugs like opioids and fentanyl. However, our country’s fight against illicit substances must be multi-faceted and we want to ensure that the appropriate attention and resources are devoted to combat these other substances...

Letter

Letters to opioid manufacturers

01.14.2020

Excerpt: "We are continuing our work investigating the causes and effects of the opioid epidemic. Last Congress, the Committee on Energy and Commerce began bipartisan investigations into fentanyl, opioid manufacturing, opioid distribution, and the substance use disorder treatment industry," the leaders write in the letters. "We write today to reactivate the investigation started on August 2, 2018, that examined potential breakdowns in the controlled substances supply chain, which may have contributed to the nation’s opioid epidemic, and the role of certain opioid manufacturers in such potential breakdowns."  

Click here to read...

Letter

Letter to Food and Drug Administration (FDA) on Good Laboratory Practices and Animal Welfare Regulations

01.09.2020

Excerpt: "On January 26, 2018, in response to animal deaths in research studies conducted by FDA’s National Center of Toxicological Research, then-FDA Commissioner Scott Gottlieb directed an independent, third-party investigation of FDA’s animal research programs. Over the last several months, Committee staff have been working with FDA to obtain documents that would provide the findings of the third-party investigation. FDA has provided an undated, unattributed summary document entitled, “Securing Animal Welfare across FDA’s research facilities,” and some email responses. However, this document indicated there were underlying audits. Additional documents are...

Letter

Letter to Chairman Pallone on 9-1-1 fee diversion

12.19.2019

Excerpt: "According to the Federal Communications Commission’s (FCC) Eleventh Annual Report to Congress, five states diverted over $197,000,000 in 9-1-1 fees for unrelated purposes, raising questions about how this practice impacts public safety," Walden and Latta write in the letter. "Our first responders and public safety professionals deserve better, and we urge you to bring legislation before the Committee expeditiously to end all diversion of 9-1-1 fees."

Click here to read the letter.

Letter

Letter to Chairman Pai regarding FCC broadband announcement

12.19.2019

Excerpt: “he recently announced 5G Fund must be allocated responsibly. The way that this fund is structured can make the difference between connecting unserved and underserved Americans or deepening the digital divide,” the Committee leaders wrote to Pai. “Just this week, the House passed legislation to improve broadband mapping and the Senate has as well. This bipartisan, bicameral support clearly shows that the Commission must collect better data before moving forward on any fund.”

Click here to read the letter.

Letter
Letter